Habib
Partner-Chief Regenerative Officer

Mr. Torfi founded Invitrx Therapeutics in 2003 and serves as Chairman and CEO. A pioneer in the field of Regenerative Stem Cell Medicine, he directed the Laboratory of Regenerative Bioengineering and Repair for the Department of Surgery at UCLA from 1998-2001. While there, his laboratory’s goal was discovering and developing proprietary, cell-based therapeutics utilizing adult stem cells derived from adipose tissue. Before that pivotal role, Mr. Torfi was the director of Epithelial Autograft Facility at UC Davis Medical Center in Sacramento, California, which provided three dimensional tissue engineered skin and cornea for burn, diabetic leg ulcer and patients with ocular surface disorders.

Mr. Torfi founded Invitrx Therapeutics in 2003 and serves as Chairman and CEO. A pioneer in the field of Regenerative Stem Cell Medicine, he directed the Laboratory of Regenerative Bioengineering and Repair for the Department of Surgery at UCLA from 1998-2001. While there, his laboratory’s goal was discovering and developing proprietary, cell-based therapeutics utilizing adult stem cells derived from adipose tissue. Before that pivotal role, Mr. Torfi was the director of Epithelial Autograft Facility at UC Davis Medical Center in Sacramento, California, which provided three dimensional tissue engineered skin and cornea for burn, diabetic leg ulcer and patients with ocular surface disorders.